Get the list of top indian stocks in share market, see and sign up for stock trading and investment tips
IDBI Bank, Bank of Maharashtra, Dena Bank:
State-owned IDBI Bank, Bank of Maharashtra and Dena Bank will be in focus on talk of receiving a capital infusion from the government in lieu of preferential allotment of shares.
ABC Bearings Ltd:
The company will be in focus after it sells entire 2.5% Stake in NSK-ABC Bearings to NSK India.
Adani Enterprises Ltd:
The company will be in focus after it said it has acquired Adani Infrastructure, which is yet to commence business operations.
Adani Power Ltd:
The Adani group will start work on its 1,600 MW ultra mega power project (UMPP) in Jharkhand in June, according to reports.
Hindustan Unilever Ltd:
The company will be in focus after it commenced commercial production at new unit in Assam plant.
Mawana Sugar Ltd:
The company will be in focus after it agreed to enter into one time settlement with PNB to resolve NPA debt.
Nila Infrastructures Ltd:
The company will be in focus after it said it has signed two pacts with Gujarat State Road Transport Corporation (GSRTC) for development of bus terminals at Amreli and Modasa in the state.
The company will be in focus after announced that the board passed an enabling resolution for exit from the investment of Rs 4.03 billion at Raidurg, Panamaktha Village.
State Bank of India:
The largest lender will be in focus after private equity firm, Carlyle has emerged as the frontrunner to partner SBI in its credit cards business and replace long-term partner GE Capital, said multiple sources aware of the matter.
The company will be in focus on board meet on Mar 24 to consider issue Of equity shares on preferential basis.
TVS Motor Ltd:
The company will be in focus after it got patent for anti break lock system.
United Bank of India:
The State-owned lender will be in focus on setting Rs 24.44 as the floor price for its Rs 15 billion QIP programme.
The company will be in focus after it has received approval from the US health regulator to market generic version of Wyeth's Zosyn, used for treating bacterial infections, in the American market.